These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers. Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514 [TBL] [Abstract][Full Text] [Related]
14. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease. Reagin H; Marks E; Weis S; Susa J Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274 [TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
16. Livedoid vasculopathy and recurrent thrombosis in a patient with lupus: seronegative antiphospholipid syndrome? Sopeña B; Pérez-Rodríguez MT; Rivera A; Ortiz-Rey JA; Lamas J; Freire-Dapena MC Lupus; 2010 Oct; 19(11):1340-3. PubMed ID: 20659971 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Fibrinolysis: How Efficacy and Safety Can Be Improved. Gurewich V J Am Coll Cardiol; 2016 Nov; 68(19):2099-2106. PubMed ID: 27810050 [TBL] [Abstract][Full Text] [Related]
18. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. Awada H; Barlowatz-Meimon G; Dougados M; Maisonneuve P; Sultan Y; Amor B J Lab Clin Med; 1988 Feb; 111(2):229-36. PubMed ID: 3123585 [TBL] [Abstract][Full Text] [Related]
19. Adalimumab in the Treatment of Recalcitrant Livedoid Vasculopathy. Bhatt DM; Bhamburkar S; Madke B; Jangid SD; Khan A Cureus; 2023 Dec; 15(12):e50053. PubMed ID: 38186477 [TBL] [Abstract][Full Text] [Related]
20. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Hairston BR; Davis MD; Gibson LE; Drage LA Arch Dermatol; 2003 Aug; 139(8):987-90. PubMed ID: 12925383 [No Abstract] [Full Text] [Related] [Next] [New Search]